Not applicable.
Not applicable.
1. Field of the Invention
The present invention relates to monitoring the vital signs of a patient and more particularly to monitoring the cardiac output of a patient.
2. Background of the Invention
In providing treatment to a patient in a hospital often the care provider needs to monitor the flow of blood in the patient. Often this includes monitoring the cardiac output, i.e. the amount of blood pumped by the heart. Current systems that use dilution principles require insertion of a catheter into a vein, for example Swan-Ganz thermodilution catheters that require heart catheterization. The catheter is generally about 2 to 4 mm in diameter and can be up to meter in length if not longer. For most adults this is not a problem since their veins and arteries are large and well developed enough to accommodate such a large device. However, for young adolescents and infants it is often impossible to use such inter arterial or venous catheters with sensors due to the small size of their arteries and veins.
There are a number of dilution methods currently available for monitoring cardiac output of children or adolescents that do not require use of catheters with sensors inserted into blood as described above. These methods are: 1) lithium dilution technique and 2) cardio-green dilution technique. The indicator used in the lithium dilution technique exhibits toxicity and requires the physician to carefully monitor the dosage to avoid an overdose. The lithium dilution technique also results in loss of blood to the patient due the need to withdraw blood that is not retuned after it makes contact with the sensor. The cardio-green dilution technique also results in loss of blood to the patient due the need for repetition of administration. Also the repetition of the tests tint the hue of the patient's skin.
Given the problems noted above related to blood loss in small patients that is unacceptable cardiac output in infant is generally monitored or measured by non invasive but less accurate methods such as Color Doppler. However, if an attending physician could safely and with a high degree of accuracy monitor blood flow in infants it would prove a great benefit.
Indicator dilution techniques have been in use for well over a century for determining blood flow including cardiac output. U.S. Pat. No. 6,155,984 describes one method and system by the inventor of the invention described in this specification. In the '984 patent an indicator introduction assembly introduces an indicator into the venous side of the central blood supply. An arterial sensor then determines the concentration of indicator as it passes the sensor after having passed through the left and right side of the heart.
While procedures, as noted above, have been developed that are less invasive than inserting of a 2 to 3 mm in diameter catheter over one meter in length, the systems currently available are still to some extent invasive and specific to certain predefined uses. Thus, what is needed is a simple and effective method and system for measuring cardiac output of an infant or adolescent, that does not required insertion of the catheter into the patient but that allows the measurement procedure to be performed outside of the patient with no blood loss. Additionally, what is needed is a system that is non-invasive, does not contaminate the patient's blood and is easy to implement. Further what is needed is a system that works with existing systems that measure other physical parameters of the patient without interfering with the operation of these existing systems.
Thus, it is an objective of the present invention to provide a noninvasive, accurate, and easy to implement method and system for measuring the cardiac output of a patient. It is a further objective to provide a method and system that can be used on infants and adolescents as well as adults. It is an additional objective of the present invention to provide a system that can be easily incorporated into existing patient monitoring and treatment systems.
The present invention achieves these and other objectives by providing: a method for determining cardiac blood output with the steps of: a) establishing an extracorporeal closed fluid circuit between an arterial cannula and a venous cannula pre-existing in an ICU patient; b.) establishing a regulated flow of blood through the closed circuit from the arterial cannula to the venous cannula with a pump; c) injecting an indicator intravenously; d) taking a reading of a blood parameter in the closed fluid circuit after the indicator has flowed at least once through the cardiopulmonary system of the patient to which the arterial and venous cannula are attached; and e) determining cardiac output from the measured blood parameter. In a further aspect of the invention the indicator is injected into the extracorporeal closed fluid circuit.
In another aspect of the present invention it provides a system for determining cardiac output in a patient having: a) a closed fluid extracorporeal circuit connecting an arterial cannula and a venous cannula in a patient; b) a least one sensor on said closed fluid circuit positioned to sense a physical parameter of a fluid flowing in the closed fluid circuit from the arterial cannula to the venous cannula; c) at least one closable access port on the closed fluid circuit, said access port configured to allow fluid access to said closed fluid circuit; d) at least one flow regulator to establish and regulate flow of blood through said closed fluid circuit; e) a processor connected to said sensor configured to receive signals from said at least one sensor and thereby determine cardiac output when blood flows from said arterial cannula to said venous cannula with indicator that has been injected into said at least one closable access port.
The invention will be better understood by an examination of the following description, together with the accompanying drawings, in which:
Patients in intensive care unit (ICU) typically have one or more intravenous catheter or cannula and intra-arterial catheter or cannula connected to them. The intravenous cannula or catheter are typically attached to a vein and allow the intravenous feeding of drugs and other substances to the patient. The intra-arterial cannulas or catheters are connected to an artery of the patient and allow the obtaining of direct and precise blood pressure readings. The readings are obtained by connecting pressure cannula to a pressure sensor through the tubing line filled usually with heparinized saline. The saline is slowly delivered into cannula to, prevent clotting.
The actual artery or vein to which the cannula is attached will depend on the requirements of the treatment. Typically the venous cannula is connected to the central venous system which could often be in a jugular vein; or a femoral vein. The arterial cannula is often connected to a radial or a femoral artery or to umbilical artery for neonatals.
A three way or standard valve system is typically connected to the end or to the extension set of the arterial cannula and venous cannula. This allows for easy access to the cannula and ultimately to the vein or artery to which the cannula is attached while allowing the access to be closed and not affect catheter performance. Similarly an intravenous feed (IV) can be inserted into the venous cannula after the appropriate valve is opened. Since it is a three way valve assembly access can be obtained through the third opening to the cannula even though an IV or sensor probe has been inserted into the second opening of the valve.
The present invention utilizes the existing venous and arterial cannula's placed in patients as standard procedure in an ICU. The present invention connects a tube between the arterial cannula and the venous cannula. This tube establishes an extracorporeal closed fluid circuit between the arterial cannula and the venous cannula. Both the arterial and venous cannula have standard valves and access ports openings 49A and 49B which allow for the control of flow of a fluid, i.e. blood flow between each cannula. The standard direction of flow in the tube is from the arterial to the venous cannula. In order to establish an adequate flow rate and avoid clotting of the blood in the extracorporeal closed fluid circuit a pump 53 is added to the line to assist and regulate the flow of blood entering the fluid circuit from the arterial cannula passing through the fluid circuit and exiting at the venous cannula, into the patient.
One or two sensors are attached to the fluid circuit to monitor the blood properties and also blood flow if needed in the circuit and take the necessary readings which are used to determine cardiac output. In the preferred embodiment of the invention ultra sound transducers are used. As depicted in
Through the sensors the system monitors cardiac output and based on readings of concentration (or values related, proportional to concentration) of indicator injected into the blood. From readings taken by the system qualitative and quantitative measurements of changes in concentration of indictor are monitored as well as the flow rate in the closed fluid circuit. Additionally, measurement and monitoring of flow through the closed extracorporeal fluid circuit is an added safety factor. Such monitoring can signal problems with flow of blood and clotting in the extracorporeal circuit.
The present invention uses indicator dilution techniques to determine cardiac output. The method of the system in its preferred embodiment includes: establishing an extracorporeal closed fluid circuit between the arterial and venous cannula 21 and starting a flow of blood 22 using a pump in the preferred embodiment, injecting an indicator such as a saline solution, into the closed fluid circuit 23. Blood starts flowing after the valves 49A, 49B and 49C have been opened to allow blood to flow into the extracorporeal closed fluid circuit from the arterial cannula and out through the venous cannula, into the patient. Pump 53 is turned on at this time to create an adequate and regulated flow of blood in the closed fluid circuit. The indicator is injected into the closed fluid circuit after blood has started to flow in the closed fluid circuit. As noted elsewhere indicator can be injected at ports located at 49A, 49B or 49C depending on the purpose of the injection. It should also be noted that in the preferred embodiment when the tubing 47 is connected to the arterial cannula 45 and venous cannula 43 the line 47 has been filled with a saline solution and measurements are taken after blood starts to enter line 47. Additionally, although the preferred embodiment discuss injecting the indicator into line 47 it can be injected intravenously at any point, such as any vein and the invention still practiced.
In the preferred embodiment readings of a blood parameter are taken in the closed fluid circuit after the indicator has flowed at least once through the cardiopulmonary circulatory system of the patient to which the arterial and venous cannula are attached 24. The readings generated by the sensors are collected by the meter and sent to computer where these readings are used to calculate cardiac output 25. The readings taken reflect the concentration of the indicator in the blood passing through the sensor location at the time of the reading. Standard indicator dilution readings are taken and used to calculate the cardiac output. In the preferred embodiment the actual signal sent by the sensor is a change in voltage representative of the speed of ultrasound transmitted through the blood flowing past the sensor location. The variation of the speed of ultrasound in the blood is representative of the concentration of indicator diluted in the blood. Since standard indicator dilution principles are used the following equation is representative of the calculation made:
In this equation Q represents the rate of cardiac output, V represents the volume of indicator and S represents the area under the dilution curve. In fact S is the combination of a series of readings of the concentration of indicator take overtime and integrated and thus it is representative of the area under the dilution curve.
The term S and its definition “area under the dilution curve” are short hand way of referring to the readings taken by the sensor. Another way to view S is as follows, when the sensor detects the presence of indicator, which by this time has passed through the cardiopulmonary circulatory system, it takes a series of readings over time and from these readings calculate S which is graphically represented by
S=∫baB dt
In this equation B is the concentration of blood as it is affected by the presence of indicator in the blood over time. This then is the integral of the time rate of change of concentration of indicator in the blood, the equivalent in integral calculus of the area under the curve. It is understood that in practice the sensor produced voltage changes that are proportional (related) to concentration changes.
In another preferred embodiment of the present invention the standard indicator dilution equation takes the following form:
In this equation Q again is the rate of cardiac output, V is the volume of indicator, S is the area under the dilution curve, which is taken from a series of readings over time of the concentration of indicator in the blood flowing past the site of the sensor. K is a calibration constant designed to relate the voltage signal received from the sensor to the concentration of indicator in the blood as it passes the sensor. It is understood that in practice the values derived from the readings are proportional or are related in a quantifiable manner to the concentration of indicator. Calibration is done in the standard manner on site or preferably the sensors, computer software and/or meter are calibrated during manufacture.
In another preferred embodiment of the present invention which involves a two sensor configuaration (
In a two sensor configuration of the system (as shown in
Arterial cannula 45 and venous cannula 43 are typically placed in an ICU patient in a hospital setting. Venous cannula 43 is used to inject into the blood stream of the patient IV's, medications being administered to the patient, as well as other substances that may be necessary for treatment. The injections go directly into the patent's blood system. Typically, the venous cannula is located in the central venous system, which often is a connection to the jugular vein. Other veins such as the femoral vein could be used. The arterial cannula is used to provide access for a catheter to periodically measure blood pressure in the patient and take blood samples. The preferred position for the arterial cannula is typically in the radial artery, or the femoral artery or umbilical artery in case of neonates.
Access valves 49A, 49B, and 49C, are three-way valves, in the preferred embodiment being three-way stopcocks. Three-way valves 49A, 49B, and 49C, allow for the complete stopping of any flow in fluid circuit 47 or allowing the flow of blood through fluid circuit 47 with or without access. Since valves 49A, 49B and 49C are three way valves all three ports of the valve can be opened to allow access to fluid circuit 47 at the same time blood is to flowing through the fluid circuit 47. The type, position and number of these values can be varied without departing from the scope and spirit of the invention.
In the preferred embodiment fluid circuit 47 is typically surgical or medical grade tubing, which extracorporeally connects at one point to arterial cannula 45, and at a second point to venous cannula 43. Extracorporeal closed fluid circuit 47 allows for the flow of blood from arterial cannula 45 to venous cannula 43. In
Indicator injection device 55 in the preferred embodiment is a syringe, which is filled with a saline or other type of indicator; and upon the proper setting of access port valve, 49A, 49B, or 49C, allows for the injection of the indicator into fluid circuit 47.
Sensor 51 in the preferred embodiment is one that measures changes in ultrasound velocity in the blood. The change in velocity being related to the amount of indicator, be it injected by such as in a saline solution or introduced as a temperature change or anyone of a number of different indicators familiar to one of ordinary skill in the art. Sensor 51 connects to flowmeter 59A. In turn Computer 59B receives the readings from flowmeter 59A calculates cardiac output based upon the readings coming from flowmeter 59A, plus additional information which the user of the system inputs into the computer program running on the computer. In the preferred embodiment the program uses the equations set forth above which have been appropriately adapted to perform the calculations necessary to determine cardiac output rate. Sensor 51 clamps around the circuit 47 and thus does not touch and contaminate the blood nor is it contaminated by the blood since they do not touch.
The single sensor system, as depicted in
The preferred embodiment of the invention actually provides for a calibration reading to translate sensor readings into concentration units. In the preferred embodiment of the single sensor system the calibration reading is obtained by injecting indicator either at port 49A or 49B, to flush the system. The flushing is intended to clear any blood away from sensor 51. Sensor 51 then begins monitoring the flow of fluid initially primed indicator in fluid circuit 47 and upon detecting blood takes a reading to provide a calibration constant. The sensor may factory recalibrated and then these is no need to calibrate it during patient measurements.
Although a saline indicator is used in the preferred embodiment any suitable indicator can be used. Other types of indicators could include a change in one or more blood characteristics, etc. These include but are not limited to thermo dilution.
The preferred embodiment described above uses a sudden injection of indicator, i.e. a bolus, to obtain the necessary reading. However, it should be noted that the present invention could be practiced with variations of the indicator dilution technique and not depart from the spirit of the present invention. Thus, the invention could also be practiced with a steady state indicator dilution technique.
The current invention is described using a preferred embodiment that uses indicator dilution, such as injecting a saline solution and sensing the presence of indicator and its concentration with an ultrasound sensor. Those of ordinary skill in the art, once they understand the principles of the current invention will realize that other physical properties of the blood can be changed and other types of sensors can be used to obtain the dilution curves without departing from the spirit of the invention. Among potential changes in blood properties possible are its optical properties, electrical proprieties (electrical impedance), thermal properties, or any other appropriate physical or chemical properties of the blood. Accordingly, optical sensors, electrical sensors, thermal sensors, or other appropriate physical or chemical sensors can be used maybe used depending on the change in the property of the blood made. Additionally, isotope tracers with appropriate sensors could be used. This is not meant to be an exhaustive list. The equations can be modified to work with different indicators which will not depart form the spirit of the invention. Also, the
While the invention has been particularly shown and described with reference to a preferred embodiment thereof, it will be understood by those skilled in the art that various changes in form and detail may be made to it without departing from the spirit and scope of the invention.
The present application claims priority under 35 USC §119 (e) from U.S. provisional application Ser. No. 60/659,205 filed Mar. 7, 2005 and entitled System and Method for Determining Cardiac Output.
Number | Date | Country | |
---|---|---|---|
60659205 | Mar 2005 | US |